Sharing a recent post on Reddit
Sorry about missing the mark on the 10-16th date.
This is what I said several days ago regarding today 10-16:
Thank you to all The LONGS here at CYDY. Thank you for tolerating my attempt at poetry. We have been here to support LL and we know it will help millions of patients suffering from many diseases. We all have been praying for CYDY to turn it around and I believe that when the clinical hold is lifted it will mark the beginning of a new improvedCYDY/LIVIMMUNE. It will be a rebirth, shedding of the old skin and with the right leadership we can begin the journey unshackled. MGK said in a response to somebody that it is time to start thinking about where CYDY goes after the clinical hold is lifted, instead of focusing on the past. I agree.
I proposed the PR to announce the lifting of the hold for this coming Monday October 16th, because we got word about the shareholder vote on 9/14 thru the delayed filing of the 10-K. I believe they would not have announced a shareholder vote until they had submitted their final “complete response” and that could have been on 9/14 or maybe 1-3 days earlier. The 9/14 date puts the ending of the FDA 30-day clock on Saturday 10/14. Thus, a PR on Monday 10/16.
As always, we are making assumptions until we hear from the company. One thing that my Monday 10/16 date does not account for is; a question from the FDA. If for some reason the FDA had a question from some page, of some paragraph in CYDY’s final submission; then the clock stops (temporarily) and will restart once the question is received by CYDY, answered, sent back, and the FDA receives CYDY’s answer(s) and declares the answer “sufficient”. This whole process may take 5-7 days (maybe less, maybe more). The clock picks up again from where it was stopped. To be clear: the 30-day calendar clock does not start over from the beginning. It starts up from where it was stopped.
I believe that the BoD, gave themselves some breathing room and set the vote for 11/9, ensuring enough time (including questions from the FDA) for the hold to be lifted and to launch a cadence of PR’s (some PR’s not all) before 11/9. If the BoD has an ounce of strategy in their collective DNA, this would be a strategic move to insure a vote “for” all things on the proxy. Plus, as I have stated before, both shareholders and the BoD need the stock price to start moving up based on positive news.
Bullish
